Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the southeastern cancer study group

Journal of Clinical Oncology

Volumn 10, Issue 2, 1992, Pages 282-291

  Roth, Bruce J ^a   Johnson, David H ^b   Einhorn, Lawrence H ^b   Schacter, Lee P ^b   Cherng, Nehemiah C ^b   Cohen, Harvey J ^b   Crawford, Jeffrey ^b   Randolph, Jaqueline A ^b   Goodlow, Janis L ^b   Broun, Goronwy O ^b   Omura, George A ^b   Greco, F Anthony ^b  

^a University of Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADULT; AGED; BONE MARROW SUPPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CISPLATIN; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG EVALUATION; ETOPOSIDE; FEMALE; HUMAN; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0026500785     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.2.282     Document Type: Article

References (33)

1. Livingston RB, Moore TN, Heilbrun L, et al: Small cell carcinoma of the lung: Combined chemotherapy and radiation. A Southwest Oncology Group Study. Ann Intern Med 88:194-199, 1978
2. Livingston RB: Long-term survivors with small cell lung cancer: A Southwest Oncology Group study. Proc Am Soc Clin Oncol 2:187, 1983 (abstr)
3. Lowenbraun S, Birch R, Buchanan R, et al: Combination chemotherapy in small cell lung carcinoma: A randomized study of two intensive regimens. Cancer 54:2344-2350, 1984
4. Johnson DH, Einhorn LH, Birch R, et al: A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 5:1731-1738, 1987
5. Loehrer PJ, Einhorn LH, Greco FA: Cisplatin plus etoposide in small cell lung cancer. Semin Oncol 15:2-8, 1988
6. Sierocki JS, Hilaris BS, Hopfan S, et al: cis-Dichlorodiammine-platinum(II) and VP-16-213: An active induction regimen for small cell carcinoma of the lung. Cane Treat Rep 63:1593-1597, 1979
7. Kim PN, McDonald DB: The combination of VP-16-213 and cisplatin in the treatment of small cell carcinoma of the lung. Proc Am Soc Clin Oncol 1:141, 1982 (abstr)
8. Evans WK, Shepherd FA, Feld R, et al: VP-16 and cisplatin as first-line therapy for small cell lung cancer. J Clin Oncol 3:1471-1477, 1985
9. Einhorn LH, Crawford J, Birch R, et al: Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin. and vincristine in limited small-cell lung cancer. J Clin Oncol 6:451-456, 1988
10. Ihde DC, Mulshine JC, Kramer BS, et al: Randomized trial of high vs. standard dose etoposide (VP-16) and cisplatin in extensive stage small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 10:240, 1991 (abstr)
11. Goldie JH, Coldman AJ, Gudauskas GA: Rationale for the use of alternating non cross-resistant chemotherapy. Cane Treat Rep 66:439-449, 1982
12. Markman M, Abeloff MD, Berkman AW, et al: Intensive alternating chemotherapy regimen in small cell carcinoma of the lung. Cancer Treat Rep 69:161-166, 1985
13. Murray N, Shah A, Wilson K, et al: Cyclic alternating chemotherapy for small cell carcinoma of the lung. Cane Treat Rep 69:1241-1242, 1985
14. Cohen MH, Ihde DC, Bunn PA, et al: Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat Rep 63:163-170, 1979
15. Natale RB, Shank B, Hilaris BS, et al: Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer. Am J Med 79:303-308, 1985
16. Cox DR, Snell ES: Analysis of Binary Data (ed 2). London, UK, Chapman and Hall, 1989
17. Peto R, Peto J: Asymptotically efficient rank invariant procedure. J R Stat Soc [A] 135:185-206, 1972
18. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure, New York, NY, Wiley and Sons, 1980
19. Cox DR: Regression models and life tables. J R Stat Soc [B] 34:187-220, 1972
20. Hryniuk WM: Average relative dose intensity and the impact on design of clinical trials. Semin Oncol 14:65-74, 1987
21. Canellos GP, Propert K, Cooper R, et al: MOPP vs. ABVD vs. MOPP alternating with ABVD in advanced Hodgkin's disease: A prospective randomized CALGB trial. Proc Am Soc Clin Oncol 7:230, 1988 (abstr)
22. Henderson IC, Hayes DF, Come S, et al: New agents and new medical treatments for advanced breast cancer. Sem Oncol 14:34-64, 1987
23. Aisner J: Alternating chemotherapy for the treatment of small cell carcinoma of the lung. Proceedings of the 13th International Congress of Chemotherapy, pp 15-23, 1983
24. Goodman GE, Crowley JJ, Blasko JC, et al: Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: A Southwest Oncology Group study. J Clin Oncol 8:39-47, 1990
25. Feld R, Evans WK, Coy P, et al: Canadian multicenter randomized trial comparing sequential and alternating administra-tion of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 5:1401-1409, 1987
26. Evans WK, Feld R, Murray N, et al: Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. Ann Intern Med 107:451-458, 1987
27. Tamura T, Fukuoka M, Furuse K, et al: Japanese multicenter randomized trial: Cyclophosphamide/Adriamycin/vincristine versus cisplatin/etoposide versus CAV alternating with PVP in patients with small-cell lung cancer. Proc Am Soc Clin Oncol 8:220, 1989 (abstr)
28. Wolf M, Pritsch M, Drings P, et al: Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: A German multicenter randomized trial of 321 patients. J Clin Oncol 9:614-624, 1991
29. Jackson D, Case D, Wells B, et al: Extended long-term survival in extensive disease small cell lung cancer treated with VP-16: Results of a randomized trial of the Piedmont Oncology Association. Proc Am Soc Clin Oncol 6:186, 1987 (abstr)
30. Hong WK, Nicaise C, Lawson R, et al: Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: A randomized trial of the Bristol Lung Cancer Study Group. J Clin Oncol 7:450-456, 1989
31. Woods RL, Levi JA: Chemotherapy for small cell lung cancer: A randomized study of maintenance therapy with cyclophosphamide, Adriamycin, and vincristine after remission induction with cisplatinum, VP-16-213 and radiotherapy. Proc Am Soc Clin Oncol 3:214, 1984 (abstr)
32. Sculier JP, Klastersky J, Libert P, et al: Cyclophosphamide, Adriamycin, and vincristine: An ineffective second-line chemotherapy for small cell lung cancer. Proc Am Soc Clin Oncol 6:184, 1987 (abstr)
33. Shepherd FA, Evans WK, MacCormick R, et al: Cyclophosphamide, doxorubicin, and vincristine in etoposide-and cisplatin-resistant small cell lung cancer. Cancer Treat Rep 71:941-944, 1987